Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2025 (Charles Schwab Trust Bank): $23M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2015 (Charles Schwab Trust Bank): $2M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2045 (Charles Schwab Trust Bank): $74M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2065 (Charles Schwab Trust Bank): $5M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2050 (Charles Schwab Trust Bank): $97M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2035 (Charles Schwab Trust Bank): $81M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2055 (Charles Schwab Trust Bank): $23M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2030 (Charles Schwab Trust Bank): $80M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2010 (Charles Schwab Trust Bank): $3M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2030 (Charles Schwab Trust Bank) (last held $67M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2050 (Charles Schwab Trust Bank) (last held $78M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2025 (Charles Schwab Trust Bank) (last held $21M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2010 (Charles Schwab Trust Bank) (last held $548,236 at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2055 (Charles Schwab Trust Bank) (last held $15M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2020 (Charles Schwab Trust Bank) (last held $9M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2035 (Charles Schwab Trust Bank) (last held $65M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2060 (Charles Schwab Trust Bank) (last held $7M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2020 (Charles Schwab Trust Bank): $9M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2015 (Charles Schwab Trust Bank) (last held $2M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2040 (Charles Schwab Trust Bank) (last held $138M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund - Income (Charles Schwab Trust Bank) (last held $1M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2040 (Charles Schwab Trust Bank): $167M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2045 (Charles Schwab Trust Bank) (last held $57M at 2024-12-31; absent from the 2025-12-31 filing)
Novo Nordisk Inc. Money Purchase Plan first reports an interest in Schwab Indexed Ret Tr Fund 2060 (Charles Schwab Trust Bank): $11M at 2025-12-31
Novo Nordisk Inc. Money Purchase Plan no longer reports Schwab Managed Ret Tr Fund 2065 (Charles Schwab Trust Bank) (last held $3M at 2024-12-31; absent from the 2025-12-31 filing)